GLP-1 Injection Industry Research Report 2025

Summary

According to APO Research, The global GLP-1 Injection market was valued at US$ million in 2024 and is anticipated to reach US$ million by 2031, witnessing a CAGR of xx% during the forecast period 2025-2031.

North American market for GLP-1 Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2026 through 2031.

Asia-Pacific market for GLP-1 Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

Europe market for GLP-1 Injection is estimated to increase from $ million in 2025 to reach $ million by 2031, at a CAGR of % during the forecast period of 2025 through 2031.

The major global manufacturers of GLP-1 Injection include , etc. In 2024, the world's top three vendors accounted for approximately % of the revenue.

Report Scope

This report aims to provide a comprehensive presentation of the global market for GLP-1 Injection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding GLP-1 Injection.

The report will help the GLP-1 Injection manufacturers, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

The GLP-1 Injection market size, estimations, and forecasts are provided in terms of sales volume (Units) and revenue ($ millions), considering 2024 as the base year, with history and forecast data for the period from 2020 to 2031. This report segments the global GLP-1 Injection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided. For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

Key Companies & Market Share Insights

In this section, the readers will gain an understanding of the key players competing. This report has studied the key growth strategies, such as innovative trends and developments, intensification of product portfolio, mergers and acquisitions, collaborations, new product innovation, and geographical expansion, undertaken by these participants to maintain their presence. Apart from business strategies, the study includes current developments and key financials. The readers will also get access to the data related to global revenue, price, and sales by manufacturers for the period 2020-2025. This all-inclusive report will certainly serve the clients to stay updated and make effective decisions in their businesses.
GLP-1 Injection Segment by Company

Zhengda Tianqing
Innovent Biologics
Wanbang Biopharma
Sihuan Pharmaceuticals
CSPC Pharmaceutical Group
Shanghai Benemae Biopharmaceuticals Co., Ltd.
Pegbio
Eli Lilly
Huadong Medicine
Hongyun Huaning
Hengrui Medicine
Hansoh Pharmaceuticals
Gan & Lee Pharmaceuticals
Borui Pharmaceuticals
Imeik
Novo Nordisk
GLP-1 Injection Segment by Type

Benaglutide
Liraglutide
Semaglutide
Tirzepatide
Others
GLP-1 Injection Segment by Application

Diabetes
Obesity
Others
GLP-1 Injection Segment by Region

North America

United States
Canada
Mexico
Europe

Germany
France
U.K.
Italy
Russia
Spain
Netherlands
Switzerland
Sweden
Poland
Asia-Pacific

China
Japan
South Korea
India
Australia
Taiwan
Southeast Asia
South America

Brazil
Argentina
Chile
Colombia
Middle East Middle East & Africa
Africa

Egypt
South Africa
Israel
Türkiye
GCC Countries

Key Drivers & Barriers

High-impact rendering factors and drivers have been studied in this report to aid the readers to understand the general development. Moreover, the report includes restraints and challenges that may act as stumbling blocks on the way of the players. This will assist the users to be attentive and make informed decisions related to business. Specialists have also laid their focus on the upcoming business prospects.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global GLP-1 Injection market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.
2. This report will help stakeholders to understand the global industry status and trends of GLP-1 Injection and provides them with information on key market drivers, restraints, challenges, and opportunities.
3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.
4. This report stays updated with novel technology integration, features, and the latest developments in the market
5. This report helps stakeholders to gain insights into which regions to target globally
6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of GLP-1 Injection.
7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Research objectives, research methods, data sources, data cross-validation;
Chapter 2: Introduces the report scope of the report, executive summary of different market segments (by region, product type, application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.
Chapter 3: Detailed analysis of GLP-1 Injection manufacturers competitive landscape, price, production and value market share, latest development plan, merger, and acquisition information, etc.
Chapter 4: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product production/output, value, price, gross margin, product introduction, recent development, etc.
Chapter 5: Production/output, value of GLP-1 Injection by region/country. It provides a quantitative analysis of the market size and development potential of each region in the next six years.
Chapter 6: Consumption of GLP-1 Injection in regional level and country level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and production of each country in the world.
Chapter 7: Provides the analysis of various market segments by type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.
Chapter 8: Provides the analysis of various market segments by application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.
Chapter 9: Analysis of industrial chain, including the upstream and downstream of the industry.
Chapter 10: Introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by manufacturers in the industry, and the analysis of relevant policies in the industry.
Chapter 11: The main points and conclusions of the report.

Please Note: Single-User license will be delivered via PDF from the publisher without the rights to print or to edit.


1 Preface
1.1 Scope of Report
1.2 Reasons for Doing This Study
1.3 Research Methodology
1.4 Research Process
1.5 Data Source
1.5.1 Secondary Sources
1.5.2 Primary Sources
2 Market Overview
2.1 Product Definition
2.2 GLP-1 Injection by Type
2.2.1 Market Value Comparison by Type (2020 VS 2024 VS 2031) & (US$ Million)
2.2.2 Benaglutide
2.2.3 Liraglutide
2.2.4 Semaglutide
2.2.5 Tirzepatide
2.2.6 Others
2.3 GLP-1 Injection by Application
2.3.1 Market Value Comparison by Application (2020 VS 2024 VS 2031) & (US$ Million)
2.3.2 Diabetes
2.3.3 Obesity
2.3.4 Others
2.4 Global Market Growth Prospects
2.4.1 Global GLP-1 Injection Production Value Estimates and Forecasts (2020-2031)
2.4.2 Global GLP-1 Injection Production Capacity Estimates and Forecasts (2020-2031)
2.4.3 Global GLP-1 Injection Production Estimates and Forecasts (2020-2031)
2.4.4 Global GLP-1 Injection Market Average Price (2020-2031)
3 Market Competitive Landscape by Manufacturers
3.1 Global GLP-1 Injection Production by Manufacturers (2020-2025)
3.2 Global GLP-1 Injection Production Value by Manufacturers (2020-2025)
3.3 Global GLP-1 Injection Average Price by Manufacturers (2020-2025)
3.4 Global GLP-1 Injection Industry Manufacturers Ranking, 2023 VS 2024 VS 2025
3.5 Global GLP-1 Injection Key Manufacturers, Manufacturing Sites & Headquarters
3.6 Global GLP-1 Injection Manufacturers, Product Type & Application
3.7 Global GLP-1 Injection Manufacturers Established Date
3.8 Global GLP-1 Injection Market CR5 and HHI
3.9 Global Manufacturers Mergers & Acquisition
4 Manufacturers Profiled
4.1 Zhengda Tianqing
4.1.1 Zhengda Tianqing GLP-1 Injection Company Information
4.1.2 Zhengda Tianqing GLP-1 Injection Business Overview
4.1.3 Zhengda Tianqing GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.1.4 Zhengda Tianqing Product Portfolio
4.1.5 Zhengda Tianqing Recent Developments
4.2 Innovent Biologics
4.2.1 Innovent Biologics GLP-1 Injection Company Information
4.2.2 Innovent Biologics GLP-1 Injection Business Overview
4.2.3 Innovent Biologics GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.2.4 Innovent Biologics Product Portfolio
4.2.5 Innovent Biologics Recent Developments
4.3 Wanbang Biopharma
4.3.1 Wanbang Biopharma GLP-1 Injection Company Information
4.3.2 Wanbang Biopharma GLP-1 Injection Business Overview
4.3.3 Wanbang Biopharma GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.3.4 Wanbang Biopharma Product Portfolio
4.3.5 Wanbang Biopharma Recent Developments
4.4 Sihuan Pharmaceuticals
4.4.1 Sihuan Pharmaceuticals GLP-1 Injection Company Information
4.4.2 Sihuan Pharmaceuticals GLP-1 Injection Business Overview
4.4.3 Sihuan Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.4.4 Sihuan Pharmaceuticals Product Portfolio
4.4.5 Sihuan Pharmaceuticals Recent Developments
4.5 CSPC Pharmaceutical Group
4.5.1 CSPC Pharmaceutical Group GLP-1 Injection Company Information
4.5.2 CSPC Pharmaceutical Group GLP-1 Injection Business Overview
4.5.3 CSPC Pharmaceutical Group GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.5.4 CSPC Pharmaceutical Group Product Portfolio
4.5.5 CSPC Pharmaceutical Group Recent Developments
4.6 Shanghai Benemae Biopharmaceuticals Co., Ltd.
4.6.1 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Company Information
4.6.2 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Business Overview
4.6.3 Shanghai Benemae Biopharmaceuticals Co., Ltd. GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.6.4 Shanghai Benemae Biopharmaceuticals Co., Ltd. Product Portfolio
4.6.5 Shanghai Benemae Biopharmaceuticals Co., Ltd. Recent Developments
4.7 Pegbio
4.7.1 Pegbio GLP-1 Injection Company Information
4.7.2 Pegbio GLP-1 Injection Business Overview
4.7.3 Pegbio GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.7.4 Pegbio Product Portfolio
4.7.5 Pegbio Recent Developments
4.8 Eli Lilly
4.8.1 Eli Lilly GLP-1 Injection Company Information
4.8.2 Eli Lilly GLP-1 Injection Business Overview
4.8.3 Eli Lilly GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.8.4 Eli Lilly Product Portfolio
4.8.5 Eli Lilly Recent Developments
4.9 Huadong Medicine
4.9.1 Huadong Medicine GLP-1 Injection Company Information
4.9.2 Huadong Medicine GLP-1 Injection Business Overview
4.9.3 Huadong Medicine GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.9.4 Huadong Medicine Product Portfolio
4.9.5 Huadong Medicine Recent Developments
4.10 Hongyun Huaning
4.10.1 Hongyun Huaning GLP-1 Injection Company Information
4.10.2 Hongyun Huaning GLP-1 Injection Business Overview
4.10.3 Hongyun Huaning GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.10.4 Hongyun Huaning Product Portfolio
4.10.5 Hongyun Huaning Recent Developments
4.11 Hengrui Medicine
4.11.1 Hengrui Medicine GLP-1 Injection Company Information
4.11.2 Hengrui Medicine GLP-1 Injection Business Overview
4.11.3 Hengrui Medicine GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.11.4 Hengrui Medicine Product Portfolio
4.11.5 Hengrui Medicine Recent Developments
4.12 Hansoh Pharmaceuticals
4.12.1 Hansoh Pharmaceuticals GLP-1 Injection Company Information
4.12.2 Hansoh Pharmaceuticals GLP-1 Injection Business Overview
4.12.3 Hansoh Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.12.4 Hansoh Pharmaceuticals Product Portfolio
4.12.5 Hansoh Pharmaceuticals Recent Developments
4.13 Gan & Lee Pharmaceuticals
4.13.1 Gan & Lee Pharmaceuticals GLP-1 Injection Company Information
4.13.2 Gan & Lee Pharmaceuticals GLP-1 Injection Business Overview
4.13.3 Gan & Lee Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.13.4 Gan & Lee Pharmaceuticals Product Portfolio
4.13.5 Gan & Lee Pharmaceuticals Recent Developments
4.14 Borui Pharmaceuticals
4.14.1 Borui Pharmaceuticals GLP-1 Injection Company Information
4.14.2 Borui Pharmaceuticals GLP-1 Injection Business Overview
4.14.3 Borui Pharmaceuticals GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.14.4 Borui Pharmaceuticals Product Portfolio
4.14.5 Borui Pharmaceuticals Recent Developments
4.15 Imeik
4.15.1 Imeik GLP-1 Injection Company Information
4.15.2 Imeik GLP-1 Injection Business Overview
4.15.3 Imeik GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.15.4 Imeik Product Portfolio
4.15.5 Imeik Recent Developments
4.16 Novo Nordisk
4.16.1 Novo Nordisk GLP-1 Injection Company Information
4.16.2 Novo Nordisk GLP-1 Injection Business Overview
4.16.3 Novo Nordisk GLP-1 Injection Production, Value and Gross Margin (2020-2025)
4.16.4 Novo Nordisk Product Portfolio
4.16.5 Novo Nordisk Recent Developments
5 Global GLP-1 Injection Production by Region
5.1 Global GLP-1 Injection Production Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
5.2 Global GLP-1 Injection Production by Region: 2020-2031
5.2.1 Global GLP-1 Injection Production by Region: 2020-2025
5.2.2 Global GLP-1 Injection Production Forecast by Region (2026-2031)
5.3 Global GLP-1 Injection Production Value Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
5.4 Global GLP-1 Injection Production Value by Region: 2020-2031
5.4.1 Global GLP-1 Injection Production Value by Region: 2020-2025
5.4.2 Global GLP-1 Injection Production Value Forecast by Region (2026-2031)
5.5 Global GLP-1 Injection Market Price Analysis by Region (2020-2025)
5.6 Global GLP-1 Injection Production and Value, YOY Growth
5.6.1 North America GLP-1 Injection Production Value Estimates and Forecasts (2020-2031)
5.6.2 Europe GLP-1 Injection Production Value Estimates and Forecasts (2020-2031)
5.6.3 China GLP-1 Injection Production Value Estimates and Forecasts (2020-2031)
5.6.4 Japan GLP-1 Injection Production Value Estimates and Forecasts (2020-2031)
6 Global GLP-1 Injection Consumption by Region
6.1 Global GLP-1 Injection Consumption Estimates and Forecasts by Region: 2020 VS 2024 VS 2031
6.2 Global GLP-1 Injection Consumption by Region (2020-2031)
6.2.1 Global GLP-1 Injection Consumption by Region: 2020-2025
6.2.2 Global GLP-1 Injection Forecasted Consumption by Region (2026-2031)
6.3 North America
6.3.1 North America GLP-1 Injection Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.3.2 North America GLP-1 Injection Consumption by Country (2020-2031)
6.3.3 United States
6.3.4 Canada
6.3.5 Mexico
6.4 Europe
6.4.1 Europe GLP-1 Injection Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.4.2 Europe GLP-1 Injection Consumption by Country (2020-2031)
6.4.3 Germany
6.4.4 France
6.4.5 U.K.
6.4.6 Italy
6.4.7 Russia
6.4.8 Spain
6.4.9 Netherlands
6.4.10 Switzerland
6.4.11 Sweden
6.4.12 Poland
6.5 Asia Pacific
6.5.1 Asia Pacific GLP-1 Injection Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.5.2 Asia Pacific GLP-1 Injection Consumption by Country (2020-2031)
6.5.3 China
6.5.4 Japan
6.5.5 South Korea
6.5.6 India
6.5.7 Australia
6.5.8 Taiwan
6.5.9 Southeast Asia
6.6 South America, Middle East & Africa
6.6.1 South America, Middle East & Africa GLP-1 Injection Consumption Growth Rate by Country: 2020 VS 2024 VS 2031
6.6.2 South America, Middle East & Africa GLP-1 Injection Consumption by Country (2020-2031)
6.6.3 Brazil
6.6.4 Argentina
6.6.5 Chile
6.6.6 Turkey
6.6.7 GCC Countries
7 Segment by Type
7.1 Global GLP-1 Injection Production by Type (2020-2031)
7.1.1 Global GLP-1 Injection Production by Type (2020-2031) & (Units)
7.1.2 Global GLP-1 Injection Production Market Share by Type (2020-2031)
7.2 Global GLP-1 Injection Production Value by Type (2020-2031)
7.2.1 Global GLP-1 Injection Production Value by Type (2020-2031) & (US$ Million)
7.2.2 Global GLP-1 Injection Production Value Market Share by Type (2020-2031)
7.3 Global GLP-1 Injection Price by Type (2020-2031)
8 Segment by Application
8.1 Global GLP-1 Injection Production by Application (2020-2031)
8.1.1 Global GLP-1 Injection Production by Application (2020-2031) & (Units)
8.1.2 Global GLP-1 Injection Production Market Share by Application (2020-2031)
8.2 Global GLP-1 Injection Production Value by Application (2020-2031)
8.2.1 Global GLP-1 Injection Production Value by Application (2020-2031) & (US$ Million)
8.2.2 Global GLP-1 Injection Production Value Market Share by Application (2020-2031)
8.3 Global GLP-1 Injection Price by Application (2020-2031)
9 Value Chain and Sales Channels Analysis of the Market
9.1 GLP-1 Injection Value Chain Analysis
9.1.1 GLP-1 Injection Key Raw Materials
9.1.2 Raw Materials Key Suppliers
9.1.3 GLP-1 Injection Production Mode & Process
9.2 GLP-1 Injection Sales Channels Analysis
9.2.1 Direct Comparison with Distribution Share
9.2.2 GLP-1 Injection Distributors
9.2.3 GLP-1 Injection Customers
10 Global GLP-1 Injection Analyzing Market Dynamics
10.1 GLP-1 Injection Industry Trends
10.2 GLP-1 Injection Industry Drivers
10.3 GLP-1 Injection Industry Opportunities and Challenges
10.4 GLP-1 Injection Industry Restraints
11 Report Conclusion
12 Disclaimer

Download our eBook: How to Succeed Using Market Research

Learn how to effectively navigate the market research process to help guide your organization on the journey to success.

Download eBook
Cookie Settings